BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17715646)

  • 1. Idiosyncratic toxic hepatitis secondary to single dose of naproxen.
    Demirag MD; Ozenirler S; Goker B; Poyraz A; Haznedaroglu S; Ozturk MA
    Acta Gastroenterol Belg; 2007; 70(2):247-8. PubMed ID: 17715646
    [No Abstract]   [Full Text] [Related]  

  • 2. A fixed-dose combination of sumatriptan and naproxen for migraine.
    Med Lett Drugs Ther; 2008 Jun; 50(1288):45-6. PubMed ID: 18551089
    [No Abstract]   [Full Text] [Related]  

  • 3. Naproxen-induced liver injury.
    Ali S; Pimentel JD; Ma C
    Hepatobiliary Pancreat Dis Int; 2011 Oct; 10(5):552-6. PubMed ID: 21947732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low dosage acetylsalicylic acid plus naproxen--a small risk of interaction].
    Holmgren HM; Schneede J
    Lakartidningen; 2011 Jun 29-Jul 19; 108(26-28):1374. PubMed ID: 21848188
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial.
    Fathi M; Zare MA; Bahmani HR; Zehtabchi S
    Am J Emerg Med; 2015 Sep; 33(9):1205-8. PubMed ID: 26166378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naproxen/esomeprazole (Vimovo).
    Med Lett Drugs Ther; 2010 Sep; 52(1347):74-5. PubMed ID: 20847717
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
    Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA
    Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross hepatotoxicity between non-steroidal anti-inflammatory drugs.
    Andrejak M; Davion T; Gineston JL; Capron JP
    Br Med J (Clin Res Ed); 1987 Jul; 295(6591):180-1. PubMed ID: 3115366
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute hepatitis after use of nimesulide: drug-induced or is there something more? Mononucleosis].
    Quadranti P
    Praxis (Bern 1994); 2004 Oct; 93(43):1785-7. PubMed ID: 15553900
    [No Abstract]   [Full Text] [Related]  

  • 10. Single nonsteroidal anti-inflammatory drug induced serum sickness-like reaction to naproxen in a patient able to tolerate both aspirin and ibuprofen.
    Koransky R; Ferastraoaru D; Jerschow E
    J Allergy Clin Immunol Pract; 2016; 4(1):160-1. PubMed ID: 26342741
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photosensitivity induced by naproxen.
    Gutiérrez-González E; Rodríguez-Pazos L; Rodríguez-Granados MT; Toribio J
    Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):338-40. PubMed ID: 22092742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: a randomized, open-label, three-period crossover study in healthy volunteers.
    Berges A; Walls C; Lener SE; McDonald SA
    Clin Ther; 2010 Jun; 32(6):1165-77. PubMed ID: 20637969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis due to pirprofen; 3 cases, 1 fatality].
    Fouin-Fortunet H; Lerebours E; Bernet J; Hemet J; Colin R
    Ann Gastroenterol Hepatol (Paris); 1986; 22(1):23-5. PubMed ID: 2938537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis secondary to current non-steroidal anti-inflammatory agents].
    Hannequin JR; Doffoel M; Schmutz G
    Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):983-8. PubMed ID: 3070713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Necrotizing cutaneous vasculitis with massive gastrointestinal bleeding following naproxen treatment].
    Horev A; Etzion O; Halevy S
    Harefuah; 2010 Mar; 149(3):157-60, 195, 194. PubMed ID: 20684166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ketoprofen-induced acute hepatitis].
    Bonaventure C; Nancey S; Pont E; Michalet V; Chevalier M; Vial T; Taieb S; Claudel S; Flourie B; Descos L
    Gastroenterol Clin Biol; 2001; 25(6-7):716-7. PubMed ID: 11673741
    [No Abstract]   [Full Text] [Related]  

  • 19. Pain relievers: bad for your heart? People with heart disease should avoid prolonged use of certain anti-inflammatory drugs, Naproxen (Aleve) is safest.
    Harv Mens Health Watch; 2013 Jan; 17(6):3. PubMed ID: 23819188
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and tolerability of naproxen ophthalmic solution in comparison to placebo.
    Papa V; Waitzinger J; Pabst G; Milazzo G; Müller M; Marrano M; Santocono M; Roth HW
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):133-40. PubMed ID: 10190761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.